TY - JOUR
T1 - What is the preparedness and capacity of palliative care services in Middle-Eastern and North African countries to respond to COVID-19?
T2 - A rapid survey
AU - Boufkhed, Sabah
AU - Harding, Richard
AU - Kutluk, Tezer
AU - Husseini, Abdullatif
AU - Pourghazian, Nasim
AU - Shamieh, Omar
N1 - Funding Information:
The authors have no conflicts of interest to disclose. The authors would like to thank Shayma'a Turki, Ayman Issa and Dr. Nour Horanieh for their help in English-Arabic translations; Ghadeer Al-Arja and Waleed Alrjoob for their help in piloting the survey; and the World Health Organization's Eastern Mediterranean Region (WHO-EMRO) network for palliative care for their support and help in data collection. Sabah Boufkhed, Richard Harding (RH), Tezer Kutluk, and Omar Shamieh are funded through the UK Research and Innovation GCRF Research for Health in Conflict (R4HC-MENA); developing capability, partnerships and research in the Middle and Near East (MENA) ES/P010962/1. The overall vision for the R4HC-MENA partnership is to build sustainable research and policy capacity in the region to address major health challenges arising from conflict. R4HC-MENA activities aim to facilitate more effective translation of research into policy and deliver impact on both the research community and for patients and vulnerable populations. Principal and Co-Investigators: Adam Coutts, Brendan Burchell, Cengiz K?l??, Deborah Mukherji, Fouad M Fouad, Ghassan Abu Sittah, Hanna Kienzler, Kai Ruggeri, Kalipso Chalkidou, Matthew Moran, Omar Shamieh, Preeti Patel, Richard Harding, Richard Sullivan, Rita Giacaman, ?evkat Bahar ?zvar??, Simon Deakin, Tezer Kutluk, Wyn Bowen. RH is funded by the National Institute of Health Research (NIHR) Global Health Research Unit on Health System Strengthening in Sub-Saharan Africa, King's College London (GHRU 16/136/54) using UK aid from the UK Government to support global health research. The views expressed are those of the authors and not necessarily those of the UK Research and Innovation GCRF or the NIHR. The funding sources had no role in the design and content of this paper. Ethical approval was obtained from King's College London Research Ethics Office (reference LRS-19/20?19091).
Publisher Copyright:
© 2020
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Context: Evidence from prior public health emergencies demonstrates palliative care's importance to manage symptoms, make advance care plans, and improve end-of-life outcomes. Objective: To evaluate the preparedness and capacity of palliative care services in the Middle-East and North Africa region to respond to the COVID-19 pandemic. Methods: A cross-sectional online survey was undertaken, with items addressing the WHO International Health Regulations. Nonprobabilistic sampling was used, and descriptive analyses were conducted. Results: Responses from 43 services in 12 countries were analyzed. Half of respondents were doctors (53%), and services were predominantly hospital based (84%). All but one services had modified at least one procedure to respond to COVID-19. Do Not Resuscitate policies were modified by a third (30%) and unavailable for a fifth (23%). While handwashing facilities at points of entry were available (98%), a third had concerns over accessing disinfectant products (37%), soap (35%), or running water (33%). The majority had capacity to use technology to provide remote care (86%) and contact lists of patients and staff (93%), though only two-fifths had relatives’ details (37%). Respondents reported high staff anxiety about becoming infected themselves (median score 8 on 1–10 scale), but only half of services had a stress management procedure (53%). Three-fifths had plans to support triaging COVID-19 patients (60%) and protocols to share (58%). Conclusion: Participating services have prepared to respond to COVID-19, but their capacity to respond may be limited by lack of staff support and resources. We propose recommendations to improve service preparedness and relieve unnecessary suffering.
AB - Context: Evidence from prior public health emergencies demonstrates palliative care's importance to manage symptoms, make advance care plans, and improve end-of-life outcomes. Objective: To evaluate the preparedness and capacity of palliative care services in the Middle-East and North Africa region to respond to the COVID-19 pandemic. Methods: A cross-sectional online survey was undertaken, with items addressing the WHO International Health Regulations. Nonprobabilistic sampling was used, and descriptive analyses were conducted. Results: Responses from 43 services in 12 countries were analyzed. Half of respondents were doctors (53%), and services were predominantly hospital based (84%). All but one services had modified at least one procedure to respond to COVID-19. Do Not Resuscitate policies were modified by a third (30%) and unavailable for a fifth (23%). While handwashing facilities at points of entry were available (98%), a third had concerns over accessing disinfectant products (37%), soap (35%), or running water (33%). The majority had capacity to use technology to provide remote care (86%) and contact lists of patients and staff (93%), though only two-fifths had relatives’ details (37%). Respondents reported high staff anxiety about becoming infected themselves (median score 8 on 1–10 scale), but only half of services had a stress management procedure (53%). Three-fifths had plans to support triaging COVID-19 patients (60%) and protocols to share (58%). Conclusion: Participating services have prepared to respond to COVID-19, but their capacity to respond may be limited by lack of staff support and resources. We propose recommendations to improve service preparedness and relieve unnecessary suffering.
UR - http://www.scopus.com/inward/record.url?scp=85099773986&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2020.10.025
DO - 10.1016/j.jpainsymman.2020.10.025
M3 - Article
C2 - 33227380
SN - 0885-3924
VL - 61
SP - E13-E50
JO - Journal of pain and symptom management
JF - Journal of pain and symptom management
IS - 2
ER -